Ultrafiltration in patients with hypervolemia and congestive heart failure

C Ronco1, Z Ricci, Alessandra Brendolan

  • 1Department of Nephrology, St. Bortolo Hospital, Vicenza, Italy. cronco@goldnet.it

Blood Purification
|January 21, 2004
PubMed

Insights

Continuous extracorporeal therapy, like hemofiltration, can stabilize hemodynamics in patients with myocardial dysfunction and fluid overload. This therapy optimizes fluid balance, reduces edema, and supports organ perfusion, aiding recovery.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Fluid overload is a common complication in patients with myocardial dysfunction, leading to various clinical issues.
  • Myocardial dysfunction can stem from reduced contractility, diastolic dysfunction, myocardial injury, or sepsis-induced myocardial depression.
  • Optimizing fluid balance, reducing edema, and managing pre- and afterload are crucial for cardiac support.

Purpose of the Study:

  • To investigate the cardiovascular effects of continuous extracorporeal therapy in patients with myocardial dysfunction and fluid overload.
  • To assess the impact of hemofiltration on myocardial elastance and hemodynamic stability.
  • To evaluate the role of ultrafiltration in maintaining circulatory blood volume and organ perfusion.

Main Methods:

  • Continuous extracorporeal therapy, specifically hemofiltration, was employed.
  • Slow continuous ultrafiltration was utilized to manage fluid balance.
  • Continuous refilling of intravascular volume from the interstitium was facilitated.

Main Results:

  • Hemofiltration demonstrated improvement in myocardial elastance and restoration of adequate fluid balance.
  • Continuous extracorporeal therapy resulted in remarkable cardiovascular stability.
  • Hemodynamic parameters including mean arterial pressure, heart rate, and systemic vascular resistance were maintained.
  • Stable circulating blood volume and preserved organ perfusion were observed.

Conclusions:

  • Continuous extracorporeal therapy offers significant cardiovascular support in patients with myocardial dysfunction and fluid overload.
  • This therapeutic approach enhances hemodynamic stability and organ perfusion.
  • It is also beneficial for renal recovery in cases of acute renal failure.

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...